La maladie de Parkinson au Canada (serveur d'exploration) - Checkpoint (PascalFrancis)

Index « FC03.fr.i » - entrée « Voie orale »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Voie nigrostriatale < Voie orale < Voie parentérale  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 16.
Ident.Authors (with country if any)Title
000401 (2009) P.-J. Blanchet [Canada] ; B. Lalonde [Canada] ; G.-J. Lavigne [Canada]Douleur orofaciale et désordres oromoteurs
000712 (2006) Kaveh M. Koochesfahani [Canada] ; Raul De La Fuente-Fernandez [Canada, Espagne] ; Vesna Sossi [Canada] ; Michael Schulzer [Canada] ; Lakshmi N. Yatham [Canada] ; Thomas J. Ruth [Canada] ; Stephan Blinder [Canada] ; A. Jon Stoessl [Canada]Oral methylphenidate fails to elicit significant changes in extracellular putaminal dopamine levels in Parkinson's disease patients : Positron emission tomographic studies
000716 (2006) Reyniel Cruz-Aguado [Canada] ; Daniella Winkler ; Christopher A. ShawLack of behavioral and neuropathological effects of dietary β-methylamino-L-alanine (BMAA) in mice
000938 (2003) Jackalina Van Kampen [Canada] ; Harold Robertson [Canada] ; Theo Hagg [Canada] ; Robert Drobitch [Canada]Neuroprotective actions of the ginseng extract G115 in two rodent models of Parkinson's disease
000A80 (2001) Richard Camicioli [États-Unis, Canada] ; Eric Lea [États-Unis] ; John G. Nutt [États-Unis] ; Gary Sexton [États-Unis] ; Barry S. Oken [États-Unis]Methylphenidate increases the motor effects of L-Dopa in Parkinson's disease: A pilot study
000B26 (2001) Oksana Suchowersky [États-Unis, Canada] ; Peter Bailey ; E. Pourcher ; Lynne Bulger ; Giovanni FacciponteComparison of two dosages of tolcapone added to levodopa in nonfluctuating patients with PD
000B32 (2001) Raul De La Fuente-Fernandez [Canada] ; Jian-Qiang Lu [Canada] ; Vesna Sossi [Canada] ; Salma Jivan [Canada] ; Michael Schulzer [Canada] ; James E. Holden [États-Unis] ; Chong S. Lee [Canada] ; Thomas J. Ruth [Canada] ; Donald B. Calne [Canada] ; A. Jon Stoessl [Canada]Biochemical variations in the synaptic level of dopamine precede motor fluctuations in Parkinson's disease : PET evidence of increased dopamine turnover
000C24 (1999) Juan Fernandez-Ruiz [États-Unis] ; Doris Doudet [Canada] ; Thomas G. Aigner [États-Unis]Spatial memory improvement by levodopa in parkinsonian MPTP-treated monkeys
000C60 (1999) V. D. Doan [Canada] ; R. Grondin [Canada] ; ABDALLAH HADJ TAHAR [Canada] ; L. Gregoire [Canada] ; P. J. Bedard [Canada]Effect of the selective D1 antagonists SCH 23390 and NNC 01-0112 on the delay, duration, and improvement of behavioral responses to dopaminergic agents in MPTP-treated monkeys
000D64 (1997) S. Rohatagi [États-Unis] ; J. S. Barrett [États-Unis] ; K. E. Dewitt [États-Unis] ; D. Lessard [Canada] ; R. J. Morales [États-Unis]Pharmacokinetic evaluation of a selegiline pulsatile oral delivery system
000E13 (1996) P. Sandor [Canada] ; A. E. Lang [Canada] ; S. Singal [Canada] ; C. Augus [Canada]Remoxipride in the treatment of levodopa-induced psychosis
001048 (1990) N. R. C. Campbell ; D. Rankine ; A. E. Goodridge ; B. B. Hasinoff ; M. KaraSinemet-ferrous sulphate interaction in patients with Parkinson's disease
001084 (1989) W. G. Vincken ; C. M. Darauay ; M. G. CosioReversibility of upper airway obstruction after levodopa therapy in Parkinson's disease
001131 (1988) T. L. Perry ; K. Jones ; S. Hansen ; R. A. Wall2-Phenylpyridine and 3-phenylpyridine, constituents of tea, are unlikely to cause idiopathic Parkinson's disease
001152 (1987) MOHAMMAD SHENASA ; M. Fromer ; G. Faugere ; R. Nadeau ; R. A. Leblanc ; C. Lambert ; MOHAMMAD ALI SADR-AMELIEfficacy and safety of intravenous and oral diltiazem for Wolff-Parkinson-White syndrome
001184 (1986) P. J. Bedard ; T. Di Paolo ; P. Falardeau ; R. BoucherChronic treatment with L-DOPA, but not bromocriptine induces dyskinesia in MPTP-Parkinsonian monkeys. Correlation with [3H]spiperone binding

List of associated Author.i

Nombre de
documents
Descripteur
2A. Jon Stoessl
2Michael Schulzer
2P. J. Bedard
2Raul De La Fuente-Fernandez
2Thomas J. Ruth
2Vesna Sossi
1A. E. Goodridge
1A. E. Lang
1ABDALLAH HADJ TAHAR
1B. B. Hasinoff
1B. Lalonde
1Barry S. Oken
1C. Augus
1C. Lambert
1C. M. Darauay
1Chong S. Lee
1Christopher A. Shaw
1D. Lessard
1D. Rankine
1Daniella Winkler
1Donald B. Calne
1Doris Doudet
1E. Pourcher
1Eric Lea
1G. Faugere
1G.-J. Lavigne
1Gary Sexton
1Giovanni Facciponte
1Harold Robertson
1J. S. Barrett
1Jackalina Van Kampen
1James E. Holden
1Jian-Qiang Lu
1John G. Nutt
1Juan Fernandez-Ruiz
1K. E. Dewitt
1K. Jones
1Kaveh M. Koochesfahani
1L. Gregoire
1Lakshmi N. Yatham
1Lynne Bulger
1M. Fromer
1M. G. Cosio
1M. Kara
1MOHAMMAD ALI SADR-AMELI
1MOHAMMAD SHENASA
1N. R. C. Campbell
1Oksana Suchowersky
1P. Falardeau
1P. Sandor
1P.-J. Blanchet
1Peter Bailey
1R. A. Leblanc
1R. A. Wall
1R. Boucher
1R. Grondin
1R. J. Morales
1R. Nadeau
1Reyniel Cruz-Aguado
1Richard Camicioli
1Robert Drobitch
1S. Hansen
1S. Rohatagi
1S. Singal
1Salma Jivan
1Stephan Blinder
1T. Di Paolo
1T. L. Perry
1Theo Hagg
1Thomas G. Aigner
1V. D. Doan
1W. G. Vincken

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Canada/explor/ParkinsonCanadaV1/Data/PascalFrancis/Checkpoint
HfdIndexSelect -h $EXPLOR_AREA/Data/PascalFrancis/Checkpoint/FC03.fr.i -k "Voie orale" 
HfdIndexSelect -h $EXPLOR_AREA/Data/PascalFrancis/Checkpoint/FC03.fr.i  \
                -Sk "Voie orale" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/PascalFrancis/Checkpoint/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Canada
   |area=    ParkinsonCanadaV1
   |flux=    PascalFrancis
   |étape=   Checkpoint
   |type=    indexItem
   |index=    FC03.fr.i
   |clé=    Voie orale
}}

Wicri

This area was generated with Dilib version V0.6.29.
Data generation: Thu May 4 22:20:19 2017. Site generation: Fri Dec 23 23:17:26 2022